Epigenetic Regulation as a New Target for Breast Cancer Therapy
- 1 January 2007
- journal article
- review article
- Published by Taylor & Francis Ltd in Cancer Investigation
- Vol. 25 (8), 659-665
- https://doi.org/10.1080/07357900701719234
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Microarray-based DNA methylation profiling: technology and applicationsNucleic Acids Research, 2006
- DNA Methyltransferase Inhibitors and the Development of Epigenetic Cancer TherapiesJNCI Journal of the National Cancer Institute, 2005
- Prospects: Histone deacetylase inhibitorsJournal of Cellular Biochemistry, 2005
- An integrated epigenetic and genetic approach to common human diseaseTrends in Genetics, 2004
- Gene Silencing in Cancer in Association with Promoter HypermethylationThe New England Journal of Medicine, 2003
- Methylation Profiling of Benign and Malignant Breast Lesions and Its Application to CytopathologyLaboratory Investigation, 2003
- A Novel Histone Deacetylase Inhibitor, Scriptaid, Enhances Expression of Functional Estrogen Receptor α (ER) in ER negative human breast cancer cells in combination with 5-aza 2′-deoxycytidineBreast Cancer Research and Treatment, 2003
- DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinomaInternational Journal of Cancer, 2003
- DNA methylation and breast carcinogenesisOncogene, 2002
- Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changesNature, 2001